Examkin

Question

Difficulty: MediumGastroenterology and Hepatology

A 42-year-old man comes to the clinic for a follow-up visit. Three weeks ago, he presented to the emergency department with a 1-week history of right upper quadrant pain, fever, and weight loss. He had recently returned from a 2-month trip to rural Mexico. At that time, a CT scan of the abdomen revealed a 6-cm, solitary, well-defined cystic lesion in the right hepatic lobe. Serologic testing was positive for a protozoal infection, and he was successfully treated with a 10-day course of oral metronidazole. His symptoms have now completely resolved, and a repeat ultrasound shows the lesion has decreased to 3 cm. His vital signs today are temperature 37.0°C (98.6°F), blood pressure 122/78 mmHg, and pulse 74/min. Physical examination reveals a soft, non-tender abdomen with normoactive bowel sounds. Laboratory studies show a leukocyte count of 7,200/mm³. He reports no current fever, abdominal pain, or changes in bowel habits. He currently works as a food prep worker at a local restaurant. Which of the following is the most appropriate next step in management?

  1. Prescribe a course of oral paromomycinAnswer
  2. B
    Prescribe a course of oral ciprofloxacin
  3. C
    Continue oral metronidazole for an additional 14 days
  4. D
    Schedule CT-guided percutaneous drainage of the liver lesion
  5. E
    Reassure the patient and schedule a follow-up visit in 6 months

Answer

The correct answer is to prescribe a course of oral paromomycin to eradicate the luminal cyst phase of the infection.
The correct next step is to prescribe a course of oral paromomycin. This patient had an amebic liver abscess caused by *Entamoeba histolytica*. The standard treatment involves a two-phase approach. The first phase uses a tissue amebicide (such as metronidazole or tinidazole) to eliminate the invasive trophozoites in the liver and intestinal wall. However, metronidazole is rapidly absorbed in the upper gastrointestinal tract and does not reach sufficient concentrations in the colon to eradicate the cyst form of the parasite. Therefore, the second phase requires a luminal amebicide (such as paromomycin, iodoquinol, or diloxanide furoate) to eliminate the intraluminal cysts. Failing to eradicate the cysts can lead to recurrent invasive disease and ongoing transmission of the parasite, which is especially concerning for a food handler.

Step-by-Step Solution

1
Identify the underlying diagnosis based on the clinical presentation and history.
The patient has an amebic liver abscess caused by Entamoeba histolytica, indicated by the travel history to an endemic area, solitary right-lobe hepatic lesion, positive protozoal serology, and rapid response to metronidazole.
Establishing the exact infectious etiology dictates the specific multiphase treatment algorithm.
2
Evaluate the current treatment status and imaging findings.
The patient has completed tissue amebicide therapy (metronidazole) with clinical resolution. The residual 3-cm lesion is an expected finding, as amebic abscesses can take months to fully resolve on imaging.
Recognizing that clinical cure does not require immediate radiographic resolution prevents unnecessary extended antibiotic courses or procedural interventions.
3
Determine the necessary pharmacological follow-up to achieve complete cure.
A luminal amebicide (e.g., paromomycin) must be administered.
Systemic tissue amebicides are heavily absorbed in the proximal GI tract and leave cysts in the colonic lumen unaffected. Eradicating these cysts is mandatory to prevent autoinfection and public transmission.

Key Concept

Treatment of amebic liver abscess requires a tissue amebicide (e.g., metronidazole) to treat the invasive disease, followed by a luminal amebicide (e.g., paromomycin) to eradicate intestinal cyst carriage.
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic